Pelthos Therapeutics Inc. (AMEX: PTHS) last traded at $20.34, up 4.20% on the session. The quote above updates while this page is open; the figures below are drawn from Pelthos Therapeutics Inc.’s own filings and are restated only when a new one is published.
Pelthos Therapeutics Inc. trades on AMEX under the ticker PTHS. Its market capitalisation is $77.87 million.
Valuation measures for Pelthos Therapeutics Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $77.87M |
|---|---|
| Enterprise value | $192.54M |
| Price / sales | 1.80 |
| Beta | 0.37 |
Trailing-twelve-month figures tagged in Pelthos Therapeutics Inc.'s XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $43.30M |
| Net income (TTM) | -$86.39M |
|---|
| EPS (TTM) | -$28.73 |
|---|
| Gross margin | 78.59% |
|---|
| Operating margin | -133.42% |
|---|
| Cash | $24.19M |
|---|
Range and volume for PTHS over the past 52 weeks.
| 52-week high | $37.50 |
|---|---|
| 52-week low | $18.19 |
| Volume | 36.2K |
| Average volume | 59.9K |
| Previous close | $19.52 |
Invest a chosen dollar amount in Pelthos Therapeutics Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PTHS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.